3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 22.16
-0.60 (-2.64%)
Apr 27, 2026, 3:59 PM HKT
3SBio Employees
3SBio had 6,109 employees as of December 31, 2025. The number of employees increased by 532 or 9.54% compared to the previous year.
Employees
6,109
Change (1Y)
532
Growth (1Y)
9.54%
Revenue / Employee
3.22M HKD
Profits / Employee
1.55M HKD
Market Cap
56.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6,109 | 532 | 9.54% | 6,109 | 0 |
| Dec 31, 2024 | 5,577 | 166 | 3.07% | 5,577 | 0 |
| Dec 31, 2023 | 5,411 | 198 | 3.80% | 5,411 | 0 |
| Dec 31, 2022 | 5,213 | -79 | -1.49% | 5,213 | 0 |
| Dec 31, 2021 | 5,292 | -236 | -4.27% | 5,292 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 21,435 |
| Genscript Biotech | 6,165 |
| Shanghai Henlius Biotech | 3,762 |
| Akeso | 3,761 |
| RemeGen | 3,048 |
| Shanghai Junshi Biosciences | 2,903 |
| Sichuan Kelun-Biotech Biopharmaceutical | 2,045 |
| Biocytogen Pharmaceuticals (Beijing) | 1,443 |
3SBio News
- 17 days ago - Mega Licensing Deal Boosts 3SBio Profits But Core Sales Slip - Benzinga